Trials / Conditions / Esophagogastric Cancer

Esophagogastric Cancer

12 registered clinical trials studyying Esophagogastric Cancer — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	PET-MRI Esophagus Feasibility Study NCT05796102	University Health Network, Toronto	N/A
Active Not Recruiting	A Study of Tooth Erosion in People With Esophagogastric Cancer NCT05612048	Memorial Sloan Kettering Cancer Center	N/A
Active Not Recruiting	A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advance NCT05544929	Novartis Pharmaceuticals	Phase 1
Active Not Recruiting	A Study of Amivantamab in People With Esophagogastric Cancer NCT05117931	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	Folfox+Irinotecan+Chemort In Esophageal Cancer NCT04656041	Massachusetts General Hospital	Phase 2
Active Not Recruiting	A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Can NCT04757363	Memorial Sloan Kettering Cancer Center	Phase 2
Completed	A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastr NCT04161781	Memorial Sloan Kettering Cancer Center	—
Active Not Recruiting	A Trial of a New Type of Photodynamic Therapy (VTP) in the Treatment of Patients With Cancer of the Esophagus NCT03133650	Memorial Sloan Kettering Cancer Center	Phase 1
Withdrawn	Personalized Therapy for Esophagogastric Cancer Using Thymidylate Synthase Genetic Markers NCT02296671	Washington University School of Medicine	Phase 2
Completed	PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer NCT02023996	Memorial Sloan Kettering Cancer Center	N/A
Completed	Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemothe NCT01803282	Gilead Sciences	Phase 1
Completed	STA-9090 in Previously Treated Patients With Advanced Esophagogastric Cancer NCT01167114	Massachusetts General Hospital	Phase 2